Notícias/Reuters/Gilead Says 75.4% Of Livdelzi Recipients Achieve ALP Normalization At Week 52 Versus 16.1% PlaceboGilead Says 75.4% Of Livdelzi Recipients Achieve ALP Normalization At Week 52 Versus 16.1% PlaceboLer o artigo completoTenha acesso ilimitado aos artigos da Reuters e de todas as outras fontes de notícias no TradingView.Continue lendo
